People leadership - Page 15
All articles
Pendragon boss gets new targets for carbon reduction, management diversity and OEM expansion
Reducing Pendragon's carbon emissions by 5%, increasing female representation in management positions and bringing at least two new OEMs on board are among the three-year targets set for the AM100 dealer group's chief executive Bill Berman and chief financial officer Mark Willis.
The Running A Modern Dealership report is here from AM
AM's latest industry special digital report, Running A Modern Dealership, has now been published. Industry experts, prominent suppliers and franchised dealers have shared their insights into the major aspects required in running a modern dealership, including used car retailing, EV sales, finance and insurance, omnichannel customer experience and aftersales efficiency.
Saker: Should HR protect employees, not the company, in sex harassment cases?
AM's regular columnist Professor Jim Saker, director of the Centre for Automotive Management at Loughborough University's business school and president of the Institute of the Motor Industry, shares his thoughts about the damage done to companies by HR departments that put corporate damage-limitation ahead of victim welfare.
Ex-Cupra duo strengthen Alpine leadership team ahead of EV product push
The Renault Group’s Alpine performance car brand has appointed new vice-presidents of sales, marketing and customer experience and sponsoring, partnerships and communications to further its pursuit of an “ambitious brand strategy”.
Constructive dismissal claim fails for technician who syphoned fuel by mouth
A technician who claimed he was driven to resign by sarcastic remarks from bosses after he swallowed petrol while syphoning fuel by mouth has lost his case against West London Motor Group.
Suzuki GB director Dale Wyatt: Parkinson’s disease ‘does not define me’
Suzuki GB director of automobile Dale Wyatt has asserted that Parkinson’s “does not define me” after taking to social media to share his approach to living with the disease more than four years after diagnosis.